Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis

Rehabilitation Psychology

Volumn 59, Issue 2, 2014, Pages 136-146

  Turner, Aaron P ^a,b,c,d   Sloan, Alicia P ^a   Kivlahan, Daniel R ^a,d   Haselkorn, Jodie K ^a,d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b VA MS Center of Excellence West   (United States)

^c Center of Excellence in Substance Abuse Treatment and Education   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Medication adherence; Motivational interviewing; Multiple sclerosis; Self management; Telehealth

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MODIFYING THERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICATION COMPLIANCE; MOTIVATIONAL INTERVIEWING; MULTIPLE SCLEROSIS; NEUROLOGICAL AND SENSORIAL PROCEDURES; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT SATISFACTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TELEHEALTH; TELEMONITORING; TELEPHONE; THERAPY EFFECT; TREATMENT DURATION; COUNSELING; MIDDLE AGED; MOTIVATION; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SELF CARE; STATISTICS AND NUMERICAL DATA; TELEMEDICINE; VETERAN;

COUNSELING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; MULTIPLE SCLEROSIS; PILOT PROJECTS; SELF CARE; TELEMEDICINE; TELEPHONE; VETERANS;

EID: 84900850494     PISSN: 00905550     EISSN: 19391544     Source Type: Journal    
DOI: 10.1037/a0036322     Document Type: Article

References (76)

1. Aronson, K. J. (1997). Quality of life among persons with multiple sclerosis and their caregivers. Neurology, 48, 74-80. doi:10.1212/WNL.48.1.74
2. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition Ed.). Washington DC: Author.
3. Beatty, W. W., Paul, R. H., Wilbanks, S. L., Hames, K. A., Blanco, C. R., & Goodkin, D. E. (1995). Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). Neurology, 45, 718-723. doi: 10.1212/WNL.45.4.718
4. Bell, K. R., Esselman, P., Garner, M. D., Doctor, J., Bombardier, C., & Johnson, K. (2003). The use of a World Wide Web-based consultation site to provide support to telephone staffin a traumatic brain injury demonstration project. Journal of Head Trauma Rehabilitation, 18, 504-511. doi:10.1097/00001199-200311000-00004
5. Bell, K. R., Temkin, N. R., Esselman, P. C., Doctor, J. N., Bombardier, C. H., & Fraser, R. T. (2005). The effect of a scheduled telephone intervention on outcome after moderate to severe traumatic brain injury: A randomized trial. Archives of Physical Medicine and Rehabilitation, 86, 851-856.
6. Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002a). Improving primary care for patients with chronic illness. Journal of the American Medical Association, 288, 1775-1779.
7. Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002b). Improving primary care for patients with chronic illness: The chronic care model, Pt. 2. Journal of the American Medical Association, 288, 1909-1914.
8. Bombardier, C. H., Bell, K. R., Temkin, N. R., Fann, J. R., Hoffman, J., & Dikmen, S. (2009). The efficacy of a scheduled telephone intervention for ameliorating depressive symptoms during the first year after traumatic brain injury. Journal of Head Trauma Rehabilitation, 24, 230-238. doi:10.1097/HTR.0b013e3181ad65f0[pii]
9. Bombardier, C. H., Cunniffe, M., Wadhwani, R., Gibbons, L. E., Blake, K. D., & Kraft, G. H. (2008). The efficacy of telephone counseling for health promotion in people with multiple sclerosis: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 89, 1849-1856.
10. Bombardier, C. H., Ehde, D. M., Gibbons, L. E., Wadhwani, R., Sullivan, M. D., & Rosenberg, D. E. (2013). Telephone-based physical activity counseling for major depression in people with multiple sclerosis. Journal of Consulting and Clinical Psychology, 81, 89-99.
11. Bruce, J. M., Bruce, A. S., Hancock, L., & Lynch, S. (2010). Self-reported memory problems in multiple sclerosis: Influence of psychiatric status and normative dissociative experiences. Archives of Clinical Neuropsychology, 25, 39-48.
12. Bruce, J. M., Hancock, L. M., & Lynch, S. G. (2010). Objective adherence monitoring in multiple sclerosis: Initial validation and association with self-report. Multiple Sclerosis, 16, 112-120.
13. Clark, N. M., & Gong, M. (2000). Management of chronic disease by practitioners and patients: Are we teaching the wrong things? British Medical Journal, 320, 572-575. doi:10.1136/bmj.320.7234.572
14. Cook, P. F., Emiliozzi, S., & McCabe, M. M. (2007). Telephone counseling to improve osteoporosis treatment adherence: An effectiveness study in community practice settings. American Journal of Medicine Quality, 22, 445-456.
15. Cook, P. F., Emiliozzi, S., Waters, C., & El Hajj, D. (2008). Effects of telephone counseling on antipsychotic adherence and emergency department utilization. American Journal of Managed Care, 14, 841-846.
16. Cook, P. F., McCabe, M. M., Emiliozzi, S., & Pointer, L. (2009). Telephone nurse counseling improves HIV medication adherence: An effectiveness study. Journal of the Association of Nurses in AIDS Care, 20, 316-325.
17. Debanne, S. M., Patterson, M. B., Dick, R., Riedel, T. M., Schnell, A., & Rowland, D. Y. (1997). Validation of a telephone cognitive assessment battery. Journal of the American Geriatrics Society, 45, 1352-1359.
18. Dellifraine, J. L., & Dansky, K. H. (2008). Home-based telehealth: A review and meta-analysis. Journal of Telemedicine and Telecare, 14, 62-66. doi:10.1258/jtt.2007.070709
19. Department of Veterans Affairs. (Producer). (2013, April 16). VHA telehealth services. Retrieved from http://vaww.telehealth.va.gov/index.asp
20. Devonshire, V., Lapierre, Y., Macdonell, R., Ramo-Tello, C., Patti, F., & Fontoura, P. (2011). The Global Adherence Project (GAP): A multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. European Journal of Neurology, 18, 69-77.
21. DiIorio, C., McCarty, F., Resnicow, K., McDonnell Holstad, M., Soet, J., & Yeager, K. (2008). Using motivational interviewing to promote adherence to antiretroviral medications: A randomized controlled study. AIDS Care, 20, 273-283.
22. Fan, V. S., Au, D., Heagerty, P., Deyo, R. A., McDonell, M. B., & Fihn, S. D. (2002). Validation of case-mix measures derived from self-reports of diagnoses and health. Journal of Clinical Epidemiology, 55, 371-380.
23. Fischer, J. S., LaRocca, N. G., Miller, D. M., Ritvo, P. G., Andrews, H., & Paty, D. (1999). Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis, 5, 251-259.
24. Fraser, C., Hadjimichael, O., & Vollmer, T. (2003). Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis. Journal of Neuroscience Nursing, 35, 163-170. doi:10.1097/01376517-200306000-00006
25. Goodkin, D. E. (1992). The natural history of multiple sclerosis. New York, NY: Springer-Verlag.
26. Gottberg, K., Einarsson, U., Ytterberg, C., de Pedro Cuesta, J., Fredrikson, S., & von Koch, L. (2006). Health-related quality of life in a populationbased sample of people with multiple sclerosis in Stockholm County. Multiple Sclerosis, 12, 605-612. doi:10.1177/1352458505070660
27. Hadjimichael, O., & Vollmer, T. (1999). Adherence to injection therapy in multiple sclerosis: Patients survey. Neurology, 52(Suppl. 2), A549.
28. Halterman, J. S., Riekert, K., Bayer, A., Fagnano, M., Tremblay, P., & Blaakman, S. (2011). A pilot study to enhance preventive asthma care among urban adolescents with asthma. Journal of Asthma, 48, 523-530. doi:10.3109/02770903.2011.576741
29. Hatzakis, M., Jr., Haselkorn, J., Williams, R., Turner, A., & Nichol, P. (2003). Telemedicine and the delivery of health services to veterans with multiple sclerosis. Journal of Rehabilitation Research and Development, 40, 265-282.
30. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, (2), CD000011. doi:10.1002/14651858.CD000011.pub3
31. Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow prescribed treatment: Clinical applications. Journal of the American Medical Association, 288, 2880-2883.
32. Haynes, R. B., McKibbon, K. A., & Kanani, R. (1996). Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348(9024), 383-386.
33. Haynes, R. B., McKibbon, K., & Kanani, R. (1997). Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348, 383-386. doi:10.1016/S0140-6736(96)01073-2
34. Haynes, R. B., Montague, P., Oliver, T., McKibbon, K. A., Brouwers, M. C., & Kanani, R. (2000). Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews, (2), CD000011.
35. Heffner, J. L., Tran, G. Q., Johnson, C. S., Barrett, S. W., Blom, T. J., & Thompson, R. D. (2010). Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy. Journal of Studies on Alcohol and Drugs, 71, 61-70.
36. Holt, C. S., & Heimberg, R. G. (1990). The Reaction to Treatment Questionnaire: Measuring treatment credibility and outcome expectancies. The Behavior Therapist, 13, 213-214, 222.
37. Ingersoll, K. S., Farrell-Carnahan, L., Cohen-Filipic, J., Heckman, C. J., Ceperich, S. D., & Hettema, J. (2011). A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+crack cocaine users. Drug and Alcohol Dependence, 116, 177-187.
38. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606-613.
39. Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444-1452. doi:10.1212/WNL.33.11.1444
40. Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York, NY: The Guilford Press.
41. Miller, W. R., & Rollnick, S. (2009). Ten things that motivational interviewing is not. Behavioural and Cognitive Psychotherapy, 37, 129-140.
42. Mohr, D. C., Boudewyn, A. C., Likosky, W., Levine, E., & Goodkin, D. E. (2001). Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Annals of Behavioral Medicine, 23, 125-132. doi:10.1207/S15324796ABM2302_7
43. Mohr, D. C., Cox, D., Epstein, L., & Boudewyn, A. (2002). Teaching patients to self-inject: Pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications. Journal of Behavior Therapy and Experimental Psychiatry, 33, 39-47. doi:10.1016/S0005-7916(02)00011-3
44. Mohr, D. C., Cox, D., & Merluzzi, N. (2005). Self-injection anxiety training: A treatment for patients unable to self-inject injectable medications. Multiple Sclerosis, 11, 182-185. doi:10.1191/1352458505ms1146oa
45. Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Baumann, K. A., & Rudick, R. A. (1997). Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Archives of Neurology, 5, 531-533. doi:10.1001/archneur.1997.00550170015009
46. Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Neilley, L. K., & Griffin, C. (1996). Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment. Multiple Sclerosis, 2, 222-226.
47. Mohr, D. C., Hart, S. L., Julian, L., Catledge, C., Honos-Webb, L., & Vella, L. (2005). Telephone-administered psychotherapy for depression. Archives of General Psychiatry, 62, 1007-1014.
48. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000). Multiple sclerosis. New England Journal of Medicine, 343, 938-952. doi:10.1056/NEJM200009283431307
49. Ogedegbe, G., Chaplin, W., Schoenthaler, A., Statman, D., Berger, D., & Richardson, T. (2008). A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. American Journal of Hypertension, 21, 1137-1143.
50. Pare, G., Jaana, M., & Sicotte, C. (2007). Systematic review of home telemonitoring for chronic diseases: The evidence base. Journal of the American Medical Informatics Association, 14, 269-277.
51. Pare, G., Moqadem, K., Pineau, G., & St-Hilaire, C. (2010). Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: A systematic review. Journal of Medicine Internet Res, 12, e21.
52. Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390-395. doi:10.1037/0022-006X.51.3.390
53. Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41, 685-691. doi:10.1212/WNL.41.5.685
54. Reid, S. C., Teesson, M., Sannibale, C., Matsuda, M., & Haber, P. S. (2005). The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: A randomized controlled trial. Journal of Studies on Alcohol, 66, 833-841.
55. Schwartz, C. E., Vollmer, T., & Lee, H. (1999). Reliability and validity of two self-report measures of impairment and disability for MS. Neurology, 52, 63-70. doi:10.1212/WNL.52.1.63
56. Siegel, S., Turner, A., & Haselkorn, J. K. (2008). Adherence to diseasemodifying therapies in multiple sclerosis: Does caregiver social support matter? Rehabilitation Psychology, 53, 73-79. doi:10.1037/0090-5550.53.1.73
57. Solomon, D. H., Iversen, M. D., Avorn, J., Gleeson, T., Brookhart, M. A., & Patrick, A. R. (2012). Osteoporosis telephonic intervention to improve medication regimen adherence: A large, pragmatic, randomized controlled trial. Archives of Internal Medicine, 172, 477-483.
58. Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. Journal of the American Medical Association, 282, 1737-1744.
59. Steinberg, S. C., Faris, R. J., Chang, C. F., Chan, A., & Tankersley, M. A. (2010). Impact of adherence to interferons in the treatment of multiple sclerosis: A non-experimental, retrospective, cohort study. Clinical Drug Investigation, 30, 89-100.
60. Stockl, K. M., Shin, J. S., Gong, S., Harada, A. S., Solow, B. K., & Lew, H. C. (2010). Improving patient self-management of multiple sclerosis through a disease therapy management program. Am J Manag Care, 16, 139-144.
61. Stone, V. E. (2001). Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice. Clinical Infectious Diseases, 33, 865-872. doi:10.1086/322698
62. Strauss, E., Sherman, E. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary. New York, NY: Oxford University Press.
63. Tan, H., Cai, Q., Agarwal, S., Stephenson, J. J., & Kamat, S. (2011). Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. Advances in Therapy, 28, 51-61. doi:10.1007/s12325-010-0093-7
64. Tremlett, H. L., & Oger, J. (2003). Interrupted therapy: Stopping and switching of the beta-interferons prescribed for MS. Neurology, 61, 551-554. doi:10.1212/01.WNL.0000078885.05053.7D
65. Turner, A. P., Kivlahan, D. R., Sloan, A. P., & Haselkorn, J. K. (2007). Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: Utility of the health beliefs model. Multiple Sclerosis, 13, 1146-1152.
66. Turner, A. P., Williams, R. M., Sloan, A. P., & Haselkorn, J. K. (2009). Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis. Rehabilitation Psychology, 54, 116-121. doi:10.1037/a0014460
67. Unverzagt, F. W., Monahan, P. O., Moser, L. R., Zhao, Q., Carpenter, J. S., & Sledge, G. W., Jr. (2007). The Indiana University telephone-based assessment of neuropsychological status: A new method for large scale neuropsychological assessment. Journal of the International Neuropsychological Society, 13, 799-806.
68. Vickers, A. J. (2001). The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Medical Research Methodology, 1, 6. doi:10.1186/1471-2288-1-6
69. Vollmer, T., Hadjimichael, O., Preiningerova, J., Ni, W., & Buenconsejo, J. (2002). Disability and treatment patterns of multiple sclerosis patients in United States: A comparison of veterans and non veterans. Journal of Rehabilitation Research and Development, 39, 163-174.
70. Von Korff, M., Gruman, J., Schaefer, J., Curry, S. J., & Wagner, E. H. (1997). Collaborative management of chronic illness. Annals of Internal Medicine, 127, 1097-1102. doi:10.7326/0003-4819-127-12-199712150-00008
71. Wagner, E. H. (2000). The role of patient care teams in chronic disease management. British Medical Journal, 320, 569-572. doi:10.1136/bmj.320.7234.569
72. Wagner, E. H., Austin, B. T., & Von Korff, M. (1996). Organizing care for patients with chronic illness. Milbank Quarterly, 74, 511-544. doi: 10.2307/3350391
73. Wechsler, D. (1997). Wechsler Adult Intelligence Scale. San Antonio, TX: Harcourt Assessment.
74. Williams, A., Manias, E., Walker, R., & Gorelik, A. (2012). A multifactorial intervention to improve blood pressure control in co-existing diabetes and kidney disease: A feasibility randomized controlled trial. Journal of Advanced Nursing, 68, 2515-2525. doi:10.1111/j.1365-2648.2012.05950.x
75. Williams, R., Turner, A., Hatzakis, M., Bowen, J., Rodriquez, A., & Haselkorn, J. (2005). Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology, 64, 75-80. doi:10.1212/01.WNL.0000148480.31424.2A
76. World Health Organization. (2003). Adherence to long term therapies: Evidence for action. Geneva, Switzerland: Author.